This is the blog for CARG, the Coronary Artery Rehabilitation Group, based in Saskatoon, Saskatchewan, Canada. It will contain items of interest to CARG's own members and anybody else interested in the latest news about rehabilitation and heart-related matters. Canadian charitable number: 89675 0163 RR 0001 || e-mail: carg.ca@gmail.com || website: carg.ca || Blog disclaimer
Showing posts with label Blood Pressure. Show all posts
Showing posts with label Blood Pressure. Show all posts
Saturday, October 19, 2013
Some blood pressure medications may reduce Alzheimer's risk
Thursday, September 19, 2013
Smart phone strategy: reminder call helps control blood pressure (USA)
Tuesday, February 21, 2012
Swimming lowers older adults' blood pressure
Saturday, February 11, 2012
Drinking eight teas a day 'cuts blood pressure and heart disease'
Monday, January 30, 2012
Blood pressure 'should be measured in both arms' (UK)
Monday, February 21, 2011
Device 'could revolutionise blood pressure monitoring' (UK)
Tuesday, January 11, 2011
Smoking around your kindergartner could raise their blood pressure
Monday, December 13, 2010
Pfizer pulls hypertension drug Thelin off the markets and ends studies because of liver damage
Thursday, October 14, 2010
Florida State study finds watermelon lowers blood pressure (USA)
Sunday, August 15, 2010
Expensive new blood pressure meds no better than generics
Saturday, May 8, 2010
Doctors 'cause blood pressure to rise' (UK)
Sunday, March 14, 2010
University of Florida researcher urges caution in reducing blood pressure in patients with diabetes, coronary disease
For patients with diabetes and heart disease, less isn't always more - at least when it comes to blood pressure. New data show an increased risk of heart attack, stroke or death for patients having blood pressure deemed too high - or too low, according to Rhonda Cooper-DeHoff, Pharm.D., an associate professor of pharmacy and medicine at UF. She reported her findings today (Sunday, March 14) at the American College of Cardiology's 59th annual scientific session in Atlanta. She recommends raising the systolic bar above 120 for blood pressure in patients with diabetes and coronary artery disease, saying that levels between 130 and 140 appear to be the most healthful. Based on hypertension treatment guidelines, health-care practitioners have assumed that with regard to blood pressure, "the lower, the better," Cooper-DeHoff said. But, The International Verapamil SR-Trandolapril study, known as INVEST, suggests that the range considered normal for healthy Americans may actually be risky for those with a combined diagnosis of diabetes and coronary artery disease. "Our data suggest that in patients with both diabetes and coronary artery disease, there is a blood pressure threshold below which cardiovascular risk increases," Cooper-DeHoff said. - EurekAlert
Thursday, January 14, 2010
Blood pressure drug offers fresh hope for dementia (UK)
Friday, October 30, 2009
NIH launches multicenter clinical trial to test blood pressure strategy (USA)
"The National Institutes of Health is launching a large multicenter randomized clinical trial to determine whether maintaining blood pressure levels lower than current recommendations further reduces the risk of cardiovascular and kidney diseases, or age-related cognitive decline. Called the Systolic Blood Pressure Intervention Trial (SPRINT), the nine-year, $114 million study will be conducted in more than 80 clinical sites across the United States. Current clinical guidelines recommend systolic pressure (the top number in a blood pressure reading) of less than 140 millimeters of mercury (mm Hg) for healthy adults, and 130 mm Hg for adults with kidney disease or diabetes. SPRINT will evaluate the potential benefits of maintaining systolic blood pressure at less than 120 mm Hg for adults who are at risk for heart disease or kidney disease. The study will also assess possible risks of this therapeutic strategy. Study participants will be treated with commonly available blood pressure medications to achieve one of two different levels of blood pressure control - either less than 140 mm Hg (standard group) or less than 120 mm Hg (treatment group). Those in the treatment group will take an average of three to four medications; those in the standard group will take about two medications. SPRINT participants will be seen in clinics every few months at the beginning of the study and less frequently as their blood pressure is controlled. The study will include standard tests for determining the health of the heart, kidneys, and brain. "
Wednesday, May 20, 2009
Heart drugs 'for all over 55s' (UK)
Thursday, May 14, 2009
Blood pressure control intervention works (Canada)
Canadian researchers say a simple, automated monitoring system helped lower patients' blood pressure. The study, published in Circulation: Cardiovascular Quality and Outcomes, found those in the intervention group showed an average reduction of 11.9 millimeters of mercury in systolic blood pressure and 6.6 mm Hg in diastolic pressure versus the control group's reductions of 7.1 mm Hg systolic and 4.5 mm Hg diastolic. "This system worked as efficaciously as if we had added a new medication on top of the patients' other medications," senior study author Dr. Pavel Hamet of the University of Montreal said in a statement. Hamet said the computer-based system asked patients for their latest blood pressure reading at least weekly and relayed the information to each patient's physician and pharmacist who then intervened if a reading presented a problem. "For example, the system alerted pharmacists when patients had not picked up their prescription refills on time," Hamet says. The study was based on 223 hypertension patients recruited through 21 physicians at eight primary care clinics in Laval, Quebec - redOrbit
Monday, May 11, 2009
Genetic link to blood pressure (UK)
"The discovery of eight new genes gives the first explanation of how blood pressure may be regulated and paves the way for developing new treatments, scientists said. Scientists at Queen Mary, University of London, jointly led an international collaboration which identified eight common genetic variants that have an influence on high blood pressure, which affects at least 18 million people in the UK. About half the patients who are treated do not achieve the recommended targets to fully reverse their risk of stroke and heart attack, the scientists said. Professor Mark Caulfield, who helped lead the study, said: "These findings are exciting because, for the first time, they give us an explanation of how blood pressure may be regulated and how individuals in the population may develop high blood pressure." - Channel 4
Subscribe to:
Posts (Atom)